165 related articles for article (PubMed ID: 23923748)
1. [Diabetes, obesity and heart complications].
Picard F; dos Santos P; Catargi B
Rev Prat; 2013 Jun; 63(6):759-64. PubMed ID: 23923748
[TBL] [Abstract][Full Text] [Related]
2. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
3. A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic population.
May O; Graversen CB; Johansen MØ; Arildsen H
J Diabetes Complications; 2017 Mar; 31(3):551-555. PubMed ID: 28065667
[TBL] [Abstract][Full Text] [Related]
4. Macrovascular Complications of Type 2 Diabetes Mellitus.
Viigimaa M; Sachinidis A; Toumpourleka M; Koutsampasopoulos K; Alliksoo S; Titma T
Curr Vasc Pharmacol; 2020; 18(2):110-116. PubMed ID: 30961498
[TBL] [Abstract][Full Text] [Related]
5. Mortality risk remains higher in individuals with type 1 diabetes: A population-based cohort study (the Ayrshire diabetes follow-up cohort [ADOC]).
Collier A; Connelly PJ; Hair M; Cameron L; Ghosh S; Waugh N
Diabetes Obes Metab; 2018 Aug; 20(8):1965-1971. PubMed ID: 29687581
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
Manson JE; Colditz GA; Stampfer MJ; Willett WC; Krolewski AS; Rosner B; Arky RA; Speizer FE; Hennekens CH
Arch Intern Med; 1991 Jun; 151(6):1141-7. PubMed ID: 2043016
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
Tkác I
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
[TBL] [Abstract][Full Text] [Related]
8. Early specialist care for diabetes: who benefits most? A propensity score-matched cohort study.
Booth GL; Shah BR; Austin PC; Hux JE; Luo J; Lok CE
Diabet Med; 2016 Jan; 33(1):111-8. PubMed ID: 25981183
[TBL] [Abstract][Full Text] [Related]
9. The diabetic cardiomyopathy.
Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
[TBL] [Abstract][Full Text] [Related]
10. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
11. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
Khunti K; Kosiborod M; Ray KK
Diabetes Obes Metab; 2018 Jun; 20(6):1337-1341. PubMed ID: 29405543
[TBL] [Abstract][Full Text] [Related]
12. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
Song SH; Hardisty CA
QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
[TBL] [Abstract][Full Text] [Related]
13. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
14. Diabetic heart disease: the story continues.
Shang Q; Yip GW
J Hum Hypertens; 2011 Mar; 25(3):141-3. PubMed ID: 20944661
[No Abstract] [Full Text] [Related]
15. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
Swidan SZ; Montgomery PA
Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
[TBL] [Abstract][Full Text] [Related]
16. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
Ussher JR
Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular manifestations of insulin resistance.
Chahwala V; Arora R
Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on diabetes mortality as the result of residual confounding and reverse causality by common disease.
Thuesen ACB; Vaag A
Diabetes Obes Metab; 2018 Jun; 20(6):1342-1349. PubMed ID: 29381250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
